UMIN-CTR Clinical Trial
| Unique ID issued by UMIN | UMIN000025406 |
|---|---|
| Receipt number | R000029169 |
| Scientific Title | Efficacy of the assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma using magnetic resonance imaging with superparamagnetic iron oxide (SPIO) |
| Date of disclosure of the study information | 2016/12/26 |
| Last modified on | 2016/12/26 14:32:25 |
* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments
Basic information
Public title
Efficacy of the assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma using magnetic resonance imaging with superparamagnetic iron oxide (SPIO)
Acronym
Efficacy of the assessment of ablative margin after RFA for HCC using MRI with SPIO
Scientific Title
Efficacy of the assessment of ablative margin after radiofrequency ablation for hepatocellular carcinoma using magnetic resonance imaging with superparamagnetic iron oxide (SPIO)
Scientific Title:Acronym
Efficacy of the assessment of ablative margin after RFA for HCC using MRI with SPIO
Region
| Japan |
Condition
Condition
Hepatocellular carcinoma
Classification by specialty
| Hepato-biliary-pancreatic medicine |
Classification by malignancy
Malignancy
Genomic information
NO
Objectives
Narrative objectives1
To clarify the relation between ablative margin and local tumor recurrence in RFA for HCC
Basic objectives2
Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase
Assessment
Primary outcomes
Local progression-free survival
Key secondary outcomes
Child-Pugh grade 6 months after RFA
Base
Study type
Interventional
Study design
Basic design
Single arm
Randomization
Non-randomized
Randomization unit
Blinding
Open -no one is blinded
Control
Uncontrolled
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment
Intervention
No. of arms
1
Purpose of intervention
Treatment
Type of intervention
| Maneuver |
Interventions/Control_1
RFA is performed within 8hrs after SPIO-enhanced MRI.
The ablative margin is evaluated with contrast-enhanced CT and non-enhanced MRI after 3days or later from RFA.
Child-Pugh score of the patient is calculated 6m after RFA.
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10
Eligibility
Age-lower limit
| 20 | years-old | <= |
Age-upper limit
| Not applicable |
Gender
Male and Female
Key inclusion criteria
Hypervascular HCC (=< 3cm and =< 3 nodules)
Detectable HCC by ultrasonography
Capable of undergoing contrast-enhanced CT
Capable of undergoing SPIO-enhanced MRI
Child-Pugh grade: A or B
Key exclusion criteria
Massive ascites
Undetectable HCC by SPIO-enhanced MRI
Target sample size
100
Research contact person
Name of lead principal investigator
| 1st name | |
| Middle name | |
| Last name | Kensaku Mori |
Organization
University of Tsukuba
Division name
Radiology
Zip code
Address
Tennodai 1-1-1, Tsukuba, Ibaraki, Japan.
TEL
+81-29-853-3205
moriken@md.tsukuba.ac.jp
Public contact
Name of contact person
| 1st name | |
| Middle name | |
| Last name | Kuniaki Fukuda |
Organization
University of Tsukuba
Division name
Gastroenterology
Zip code
Address
Tennodai 1-1-1, Tsukuba, Ibaraki, Japan.
TEL
+81-29-853-3218
Homepage URL
k-fukuda@md.tsukuba.ac.jp
Sponsor or person
Institute
University of Tsukuba
Institute
Department
Personal name
Funding Source
Organization
none
Organization
Division
Category of Funding Organization
Other
Nationality of Funding Organization
Other related organizations
Co-sponsor
Name of secondary funder(s)
IRB Contact (For public release)
Organization
Address
Tel
Secondary IDs
Secondary IDs
NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW
Institutions
Institutions
Other administrative information
Date of disclosure of the study information
| 2016 | Year | 12 | Month | 26 | Day |
Related information
URL releasing protocol
Publication of results
Unpublished
Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description
Progress
Recruitment status
Completed
Date of protocol fixation
| 2007 | Year | 11 | Month | 15 | Day |
Date of IRB
Anticipated trial start date
| 2008 | Year | 04 | Month | 01 | Day |
Last follow-up date
| 2015 | Year | 12 | Month | 31 | Day |
Date of closure to data entry
| 2016 | Year | 06 | Month | 30 | Day |
Date trial data considered complete
| 2016 | Year | 09 | Month | 30 | Day |
Date analysis concluded
| 2016 | Year | 11 | Month | 30 | Day |
Other
Other related information
Management information
Registered date
| 2016 | Year | 12 | Month | 26 | Day |
Last modified on
| 2016 | Year | 12 | Month | 26 | Day |
Link to view the page
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029169
